Clinical trial
Rosuvastatin for Hepatitis C
NCT00371579 · UMC Utrecht, Other · Withdrawn
Key facts
| NCT number | NCT00371579 |
|---|---|
| Title | Rosuvastatin for Hepatitis C |
| Official title | Treatment With Rosuvastatin in Patients With Hepatitis C |
| Lead sponsor | UMC Utrecht, Other |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | rosuvastatin |
| Enrollment | 0 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 4, 2006 |
| Last update posted | Jun 3, 2015 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: